Detailed answers about SMI DRUG DISCOVERY LIMITED, including incorporation, status, business activity, and accounts information.
When was SMI DRUG DISCOVERY LIMITED founded?
SMI DRUG DISCOVERY LIMITED was officially incorporated on 29 January 2018 and is registered under company number 11175710. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SMI DRUG DISCOVERY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SMI DRUG DISCOVERY LIMITED?
SMI DRUG DISCOVERY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SMI DRUG DISCOVERY LIMITED do?
SMI DRUG DISCOVERY LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is SMI DRUG DISCOVERY LIMITED's registered address?
The registered office address of SMI DRUG DISCOVERY LIMITED is 23 LONGMEADOW, LODE, CAMBRIDGE, UNITED KINGDOM, CB25 9HA. This is the official address filed with Companies House for legal and statutory correspondence.
Is SMI DRUG DISCOVERY LIMITED financially stable?
The most recent accounts for SMI DRUG DISCOVERY LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.